Medasense
Medasense54
About
What does Medasense do?
Medasense is transforming pain assessment and treatment globally. Their breakthrough NOL® AI technology and sensing platform objectively quantify pain response, enabling clinicians to optimize care and prevent overmedication. The flagship product, PMD-200™, is utilized in critical care settings.
What is Medasense's valuation?
StartupHub estimates Medasense's effective valuation at $161.6M (range $99.0M to $237.6M, 10% confidence), based on comparable companies in the sector.
How much funding has Medasense raised?
Medasense has raised a total of $40M in funding. The most recent round on record is Series C.
Where is Medasense headquartered?
Medasense is headquartered in Tel Aviv, Israel.
When was Medasense founded?
Medasense was founded in 2008.
What industry does Medasense operate in?
Medasense operates in Pain, Patient Care, Monitoring, Surgery, Healthcare, Digital Health.
How many employees does Medasense have?
Medasense has approximately 26 people on record.
What is Medasense's current status?
Medasense's current operating status is: Inactive.
Agent Watch provides a dashboard to monitor, control, and receive alerts from AI coding agents, tracking costs and performance.
Logkit provides a unified platform for logging, monitoring, and debugging applications.
AgenticISP provides 24/7 network engineering for ISPs, monitoring, diagnosing, and acting with team authority.
An entrant is a company tagged Monitoring whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.